Ultragenyx Pharmaceutical, Inc. (RARE)
22.87
+0.42
(+1.87%)
USD |
NASDAQ |
Apr 06, 16:00
22.86
0.00 (0.00%)
After-Hours: 20:00
Ultragenyx Pharmaceutical Market Cap : 2.251B for April 6, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Corcept Therapeutics, Inc. | 4.178B |
| BioMarin Pharmaceutical, Inc. | 10.95B |
| Catalyst Pharmaceuticals, Inc. | 3.087B |
| Regeneron Pharmaceuticals, Inc. | 80.80B |
| Xencor, Inc. | 887.41M |
Market Cap Related Metrics
| PS Ratio | 3.414 |
| Price | 22.87 |
| Earnings Yield | -25.06% |